Visceral metastases, platelet dynamics, and PSA decline: from biomarkers to better outcomes in [<sup>177</sup>Lu]Lu‑PSMA‑617 therapy in metastatic castration-resistant prostate cancer
Authors: Nathan Poterszman, Cécile Hammer-Lefevre, Clémence Porot, Julien Salvadori, Philippe Barthélémy, François Somme